Botanical New Drug
Innovation for dermatology
Botanical new drugs are developed by extracting natural active ingredients from plants, undergoing rigorous scientific experiments and clinical trials to ensure their quality, safety, and efficacy, ultimately resulting in medications for the prevention or treatment of diseases.
SCROLL DOWN
New Drug Development Progress
New Drug Development Progress
GM-XANTHO
Indications：Atopic Dermatitis
GM-XANTHO stands out as the world's only botanical drug for atopic dermatitis.
Phase II
Phase III
Market
2026 Q1
1
1
Project Initiation
Pre-Clinical
IND
Phase I
Phase II
Phase III
Market
2026 Q1
-
GM-XANTHO
About us
Innovation, Excellence, Trust, and Sustainability.
Xantho Bio., established in 2014, focuses on developing botanical new drugs with low side effects. We aims to develop topical treatments for long-term use, offering physicians and patients alternatives to topical steroids and immunosuppressants.
Botanical New Drug
Xantho Bio. is dedicated to treating skin diseases, developing niche medications suitable for all age groups to enhance quality of life.
Immunity & inflammation
GM-XANTHO is a topical use botanical new drug for treating atopic dermatitis, with Phase II clinical trials expected to be completed in Q1 2025.
News & Events
News
MORE
2026 Bio Asia Taiwan
BIO Asia-Taiwan 2026 Exhibition Announcement
July 2026
MORE
Latest News: Xantho Biotechnology Participates in 2025 Bio-Europe Conference, Actively Expanding International Licensing and Collaboration for GM-XANTHO
Latest News: Xantho Biotechnology Participates in 2025 Bio-Europe Conference, Actively Expanding International Licensing and Collaboration for GM-XANTHO
December 2025
Exhibition
MORE
XANTHO Bio Seeks International Licensing, Initiates Phase 2b Clinical Trial
XANTHO Bio Seeks International Licensing, Initiates Phase 2b Clinical Trial
July 2025
News
MORE
Congrats! Australian Patent for GM-XAN003 Granted – A New Breakthrough in Psoriasis Treatment!
Congrats! Australian Patent for GM-XAN003 Granted – A New Breakthrough in Psoriasis Treatment!
April 2025
News
MORE
Congrats! Tawain Patent for GM-XAN003 Granted- A New Breakthrough in Psoriasis Treatment
Congrats! Tawain Patent for GM-XAN003 Granted- A New Breakthrough in Psoriasis Treatment
February 2025
News
MORE
Congrats! New Drug Nominated for Edison Award, Highlighting Innovation and Strength
The Edison Award is regarded as the "Oscar" in the fields of innovation and business, recognizing the most groundbreaking products and technologies worldwide. Xantho Bio is committed to developing treatments for chronic inflammatory skin diseases using botanical ingredients.
January 2025
News
MORE
GM-XANTHO successfully achieved the clinical trial enrollment milestone in January 2025!
Xantho Bio successfully completed the "A Phase I/IIa Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GMXANTHO in Healthy Volunteers and to Investigate its Efficacy and Safety Profile in Atopic Dermatitis Patients" clinical trial enrollment (Last Subject Out, LSO) milestone in January 2025 !
January 2025
News
MORE
Xantho Bio. presented in The 50th Annual Meeting of Taiwanese Dermatological Association
Xantho Bio. participated in the 50th Annual Meeting of the Taiwanese Dermatological Association (TDA), held on November 15-17, 2024, at the Taipei International Convention Center.
November 2024
News
MORE
Xantho Bio. participated and presented in NPIC 2024 International Symposium on Natural Product Innovation and Commercialization
Xantho Bio. participated and presented in NPIC 2024 International Symposium on Natural Product Innovation and Commercialization
November 2024
Exhibition
MORE
Xantho Bio. attended Bio Japan 2024 for global business partnering
The CEO and BD manager of Xantho Bio. attended Bio Japan 2024, one of the largest Bio convention in Asia, held in PACIFICO Yokohama Convention Center, Japan (from October 9 to October 11). During the 3-day event, Xantho Bio. participated in the one-on-one partnering meetings with international pharmaceutical companies to discuss drug licensing opportunities.
October 2024
Exhibition